NeoGenomics (NEO)
NASDAQ:NEO
Holding NEO?
Track your performance easily

NeoGenomics (NEO) Financial Statements

1,786 Followers

NeoGenomics Financial Overview

NeoGenomics's market cap is currently ―. The company's EPS TTM is $-0.623; its P/E ratio is -23.96; NeoGenomics is scheduled to report earnings on February 25, 2025, and the estimated EPS forecast is $0.03. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 167.82M$ 164.50M$ 156.24M$ 155.55M$ 151.95M
Gross Profit$ 74.88M$ 72.49M$ 65.47M$ 67.59M$ 62.31M
EBIT$ -17.85M$ -19.02M$ -26.00M$ -1.55M$ -24.29M
EBITDA$ 866.00K$ -183.00K$ -7.00M$ 17.54M$ -5.44M
Net Income Common Stockholders$ -17.70M$ -18.64M$ -27.06M$ -14.33M$ -18.52M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 387.81M$ 387.86M$ 384.83M$ 415.20M$ 402.26M
Total Assets$ 1.64B$ 1.64B$ 1.64B$ 1.68B$ 1.68B
Total Debt$ 606.27M$ 606.52M$ 608.18M$ 611.68M$ 605.70M
Net Debt$ 218.46M$ 218.66M$ 223.35M$ 196.48M$ 203.44M
Total Liabilities$ 732.90M$ 727.39M$ 716.93M$ 739.69M$ 730.81M
Stockholders Equity$ 908.21M$ 915.88M$ 923.41M$ 941.54M$ 947.43M
Cash Flow-
Free Cash Flow$ -1.55M$ 814.00K$ -31.50M$ 10.73M$ -9.77M
Operating Cash Flow$ 9.25M$ 13.89M$ -25.91M$ 17.78M$ -5.50M
Investing Cash Flow$ -3.52M$ 7.31M$ 14.53M$ 17.20M$ 20.82M
Financing Cash Flow$ 1.18M$ 1.97M$ 816.00K$ 1.27M$ 1.84M
Currency in USD

NeoGenomics Earnings and Revenue History

NeoGenomics Debt to Assets

NeoGenomics Cash Flow

NeoGenomics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis